Ethical Compliance
BLISS GVS PHARMA
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
1.5%
Debt
7.2%
Liquidity
17.8%
Revenue
Debt
Liquidity
1.5%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Income | ₹16.77 |
| Pharmaceuticals | ₹764.11 |
| Sale of services | ₹1.80 |
| Export incentives | ₹4.34 |
Questionable
INR Crores
| Net Gain on Sale of Investments | ₹0.17 |
Non Compliant
INR Crores
| Interest income | ₹11.79 |
INR Crores
| Revenue from Questionable Sources: | ₹0.17 |
| Revenue from Non Compliant Sources: | ₹11.79 |
| Total: | ₹11.96 |
| Total Revenue: | ₹798.98 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹11.96
₹798.98
= 1.5%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
